PyInvesting

Market research

PBV.F Prestige Consumer Healthcare Inc

F EUR Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
2B
P/E ratio
14.36
Analyst target
63.5
Dividend yield
Not available
Beta
0.33

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Prestige Consumer Healthcare Inc is currently in a long term uptrend where the price is trading 22.5% above its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 2.3.

Prestige Consumer Healthcare Inc's total revenue sank by 1.1% to $239M since the same quarter in the previous year.

Its net income has increased by 7.4% to $41M since the same quarter in the previous year.

Finally, its free cash flow fell by 20.6% to $43M since the same quarter in the previous year.

Based on the above factors, Prestige Consumer Healthcare Inc gets an overall score of 3/5.